MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 44 filers reported holding MIRAGEN THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,226,000 | -30.3% | 1,581,818 | -0.2% | 0.00% | – |
| Q2 2020 | $1,759,000 | +145.0% | 1,584,420 | -1.6% | 0.00% | – |
| Q1 2020 | $718,000 | +130.1% | 1,610,743 | +147.3% | 0.00% | – |
| Q4 2019 | $312,000 | -34.6% | 651,343 | 0.0% | 0.00% | – |
| Q3 2019 | $477,000 | -62.4% | 651,343 | +5.4% | 0.00% | – |
| Q2 2019 | $1,267,000 | +1.2% | 617,914 | +37.7% | 0.00% | – |
| Q1 2019 | $1,252,000 | -3.7% | 448,828 | +4.6% | 0.00% | – |
| Q4 2018 | $1,300,000 | -73.0% | 428,896 | -50.3% | 0.00% | – |
| Q3 2018 | $4,818,000 | -13.8% | 863,346 | -1.0% | 0.00% | – |
| Q2 2018 | $5,591,000 | -2.3% | 872,271 | +6.9% | 0.00% | – |
| Q1 2018 | $5,720,000 | +34.5% | 816,002 | +100.2% | 0.00% | – |
| Q4 2017 | $4,252,000 | +968.3% | 407,612 | +837.8% | 0.00% | – |
| Q3 2017 | $398,000 | -25.2% | 43,465 | +5.5% | 0.00% | – |
| Q2 2017 | $532,000 | +309.2% | 41,187 | +294.6% | 0.00% | – |
| Q1 2017 | $130,000 | – | 10,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|